Pritus Tablet 50 mg (Franolukast Hydrate)

Adult dose

Adults: Administer 50mg of pranlukast hydrate orally twice daily, after breakfast and dinner. Adjust the dose as appropriate according to symptoms.

This medication should not be used in patients who have allergic reactions to this medication or its components. This medication contains lactose, so patients with genetic disorders who cannot digest lactose should not take it. When taking this medication, serious allergic reactions such as shock or anaphylaxis may occur, and symptoms should be closely monitored. There may be blood-related side effects such as a decrease in white blood cell or platelet counts; if symptoms such as fever or bleeding occur, discontinue use immediately. Liver function abnormalities may occur; if symptoms such as jaundice or elevated liver enzyme levels appear, stop taking this medication and seek treatment. If respiratory problems occur, such as fever, cough, or difficulty breathing, discontinue use and seek appropriate treatment. Muscle-related issues may arise, so if symptoms such as muscle pain, weakness, or muscle damage occur, discontinue use and be cautious of acute kidney failure. If hypersensitivity reactions such as skin rash, hives, or itching occur, stop taking this medication and take appropriate action. Psychoneurological symptoms such as tremors, seizures, anxiety, headaches, drowsiness, or dizziness may occur, so caution is required with any abnormal symptoms. Gastrointestinal symptoms such as nausea, abdominal pain, diarrhea, vomiting, or loss of appetite may occur, so pay attention to symptoms. Cardiovascular symptoms such as arrhythmias or palpitations, flushing may rarely occur. Urinary issues such as protein in urine or micturition disorders may happen, so inform your healthcare provider of any unusual symptoms. Additionally, fatigue, weight gain, hair loss, menstrual irregularities, and other various side effects have been reported; caution is needed if symptoms occur. This medication is not an immediate relief for asthma attacks, so this should be clearly explained to the patient. In severe asthma attacks, bronchodilators or steroids may need to be used in conjunction with this medication. If long-term steroid treatment is being given, when taking this medication, the steroid dosage should be reduced gradually. Discontinuing this medication should be done with caution as the original condition may worsen. Serious immune reactions such as vasculitis may appear during the course of this medication, so eosinophil levels and related symptoms should be closely monitored. It may affect mental health, so if symptoms such as depression or suicidal thoughts appear, consult healthcare professionals immediately. If there is no effect, it is advisable not to continue taking it for a long time. This medication is metabolized by a specific enzyme (CYP3A4) in the liver, so taking it with other medications that affect this enzyme may change blood concentrations. Women who are pregnant or may become pregnant should carefully consider the benefits and risks of taking this medication. Caution is needed for children, especially low-birth-weight infants or newborns, as safety has not been sufficiently established. For the elderly, it is recommended to reduce the dosage as physical functions may decline. This medication should be kept out of the reach of children, and transferring it to another container may pose a risk of accidents and degradation of quality.

• Shock
• symptoms resembling anaphylaxis
• decreased blood pressure
• altered consciousness
• shortness of breath
• rash
• leukopenia
• fever
• sore throat
• general malaise

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance

White or light yellow rectangular film-coated tablets

Package unit

Bottle package - 30 tablets/bottle, Bottle package - 300 tablets/bottle